ENTRY       hsa04936                    Pathway
NAME        Alcoholic liver disease - Homo sapiens (human)
DESCRIPTION Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
CLASS       Human Diseases; Endocrine and metabolic disease
PATHWAY_MAP hsa04936  Alcoholic liver disease
DISEASE     H02516  Alcoholic liver disease
DRUG        D12391  Denifanstat (USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            100293534  C4B_2; complement component 4B (Chido/Rodgers blood group), copy 2 [KO:K03989]
            10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]
            10645  CAMKK2; calcium/calmodulin dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]
            10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]
            110384692  [KO:K03989]
            114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            124  ADH1A; alcohol dehydrogenase 1A (class I), alpha polypeptide [KO:K13951] [EC:1.1.1.1]
            125  ADH1B; alcohol dehydrogenase 1B (class I), beta polypeptide [KO:K13951] [EC:1.1.1.1]
            126  ADH1C; alcohol dehydrogenase 1C (class I), gamma polypeptide [KO:K13951] [EC:1.1.1.1]
            126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]
            127  ADH4; alcohol dehydrogenase 4 (class II), pi polypeptide [KO:K13980] [EC:1.1.1.1]
            128  ADH5; alcohol dehydrogenase 5 (class III), chi polypeptide [KO:K00121] [EC:1.1.1.284 1.1.1.1]
            130  ADH6; alcohol dehydrogenase 6 (class V) [KO:K13952] [EC:1.1.1.1]
            131  ADH7; alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide [KO:K13951] [EC:1.1.1.1]
            1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]
            1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]
            1499  CTNNB1; catenin beta 1 [KO:K02105]
            1571  CYP2E1; cytochrome P450 family 2 subfamily E member 1 [KO:K07415] [EC:1.14.14.-]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2168  FABP1; fatty acid binding protein 1 [KO:K08750]
            217  ALDH2; aldehyde dehydrogenase 2 family member [KO:K00128] [EC:1.2.1.3]
            219  ALDH1B1; aldehyde dehydrogenase 1 family member B1 [KO:K00128] [EC:1.2.1.3]
            2194  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]
            223  ALDH9A1; aldehyde dehydrogenase 9 family member A1 [KO:K00149] [EC:1.2.1.47 1.2.1.3]
            224  ALDH3A2; aldehyde dehydrogenase 3 family member A2 [KO:K00128] [EC:1.2.1.3]
            2308  FOXO1; forkhead box O1 [KO:K07201]
            2309  FOXO3; forkhead box O3 [KO:K09408]
            23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]
            23175  LPIN1; lipin 1 [KO:K15728] [EC:3.1.3.4]
            23411  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]
            23417  MLYCD; malonyl-CoA decarboxylase [KO:K01578] [EC:4.1.1.9]
            23643  LY96; lymphocyte antigen 96 [KO:K05400]
            23765  IL17RA; interleukin 17 receptor A [KO:K05164]
            257397  TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3 [KO:K12793]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]
            2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]
            2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]
            2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            29896  TRA2A; transformer 2 alpha homolog [KO:K12897]
            31  ACACA; acetyl-CoA carboxylase alpha [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
            32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
            34  ACADM; acyl-CoA dehydrogenase medium chain [KO:K00249] [EC:1.3.8.7]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            356  FASLG; Fas ligand [KO:K04389]
            3569  IL6; interleukin 6 [KO:K05405]
            3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]
            3592  IL12A; interleukin 12A [KO:K05406]
            3593  IL12B; interleukin 12B [KO:K05425]
            3605  IL17A; interleukin 17A [KO:K05489]
            3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            37  ACADVL; acyl-CoA dehydrogenase very long chain [KO:K09479] [EC:1.3.8.9]
            3929  LBP; lipopolysaccharide binding protein [KO:K05399]
            406999  MIR217; microRNA 217 [KO:K17125]
            4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
            4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            501  ALDH7A1; aldehyde dehydrogenase 7 family member A1 [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
            50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]
            51  ACOX1; acyl-CoA oxidase 1 [KO:K00232] [EC:1.3.3.6]
            51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]
            51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]
            51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
            51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]
            53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]
            5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]
            5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.31]
            5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.31]
            5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]
            5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]
            5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            595  CCND1; cyclin D1 [KO:K04503]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            6319  SCD; stearoyl-CoA desaturase [KO:K00507] [EC:1.14.19.1]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            6434  TRA2B; transformer 2 beta homolog [KO:K12897]
            64900  LPIN3; lipin 3 [KO:K15728] [EC:3.1.3.4]
            6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]
            6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            6932  TCF7; transcription factor 7 [KO:K02620]
            6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            712  C1QA; complement C1q A chain [KO:K03986]
            7124  TNF; tumor necrosis factor [KO:K03156]
            713  C1QB; complement C1q B chain [KO:K03987]
            7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]
            714  C1QC; complement C1q C chain [KO:K03988]
            717  C2; complement C2 [KO:K01332] [EC:3.4.21.43]
            718  C3; complement C3 [KO:K03990]
            7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            719  C3AR1; complement C3a receptor 1 [KO:K04009]
            720  C4A; complement C4A (Chido/Rodgers blood group) [KO:K03989]
            721  C4B; complement C4B (Chido/Rodgers blood group) [KO:K03989]
            727  C5; complement C5 [KO:K03994]
            728  C5AR1; complement C5a receptor 1 [KO:K04010]
            79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]
            79966  SCD5; stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]
            8310  ACOX3; acyl-CoA oxidase 3, pristanoyl [KO:K00232] [EC:1.3.3.6]
            83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            84818  IL17RC; interleukin 17 receptor C [KO:K05166]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]
            8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
            8772  FADD; Fas associated via death domain [KO:K02373]
            9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
            929  CD14; CD14 molecule [KO:K04391]
            9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]
            9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
            9663  LPIN2; lipin 2 [KO:K15728] [EC:3.1.3.4]
COMPOUND    C00003  NAD+
            C00005  NADPH
            C00006  NADP+
            C00024  Acetyl-CoA
            C00033  Acetate
            C00040  Acyl-CoA
            C00076  Calcium cation
            C00083  Malonyl-CoA
            C00084  Acetaldehyde
            C00469  Ethanol
            C22381  Reactive oxygen species
REFERENCE   PMID:25782093
  AUTHORS   Louvet A, Mathurin P
  TITLE     Alcoholic liver disease: mechanisms of injury and targeted treatment.
  JOURNAL   Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
            DOI:10.1038/nrgastro.2015.35
REFERENCE   PMID:21920463
  AUTHORS   Gao B, Bataller R
  TITLE     Alcoholic liver disease: pathogenesis and new therapeutic targets.
  JOURNAL   Gastroenterology 141:1572-85 (2011)
            DOI:10.1053/j.gastro.2011.09.002
REFERENCE   PMID:28134813
  AUTHORS   Magdaleno F, Blajszczak CC, Nieto N
  TITLE     Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  JOURNAL   Biomolecules 7:E9 (2017)
            DOI:10.3390/biom7010009
REFERENCE   PMID:19553649
  AUTHORS   Lucey MR, Mathurin P, Morgan TR
  TITLE     Alcoholic hepatitis.
  JOURNAL   N Engl J Med 360:2758-69 (2009)
            DOI:10.1056/NEJMra0805786
REFERENCE   PMID:26919968
  AUTHORS   Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  TITLE     Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  JOURNAL   Gastroenterology 150:1756-68 (2016)
            DOI:10.1053/j.gastro.2016.02.035
REFERENCE   PMID:25009376
  AUTHORS   Fujii H, Kawada N
  TITLE     Fibrogenesis in alcoholic liver disease.
  JOURNAL   World J Gastroenterol 20:8048-54 (2014)
            DOI:10.3748/wjg.v20.i25.8048
REFERENCE   PMID:26755857
  AUTHORS   Kim MS, Ong M, Qu X
  TITLE     Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  JOURNAL   World J Gastroenterol 22:8-23 (2016)
            DOI:10.3748/wjg.v22.i1.8
REFERENCE   PMID:15194557
  AUTHORS   You M, Crabb DW
  TITLE     Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  JOURNAL   Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
            DOI:10.1152/ajpgi.00056.2004
REFERENCE   PMID:26695748
  AUTHORS   Nagy LE
  TITLE     The Role of Innate Immunity in Alcoholic Liver Disease.
  JOURNAL   Alcohol Res 37:237-50 (2015)
REFERENCE   PMID:21252049
  AUTHORS   Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  TITLE     Innate immunity in alcoholic liver disease.
  JOURNAL   Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
            DOI:10.1152/ajpgi.00537.2010
REFERENCE   PMID:22524187
  AUTHORS   Wang HJ, Gao B, Zakhari S, Nagy LE
  TITLE     Inflammation in alcoholic liver disease.
  JOURNAL   Annu Rev Nutr 32:343-68 (2012)
            DOI:10.1146/annurev-nutr-072610-145138
REFERENCE   PMID:29597356
  AUTHORS   McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  TITLE     Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  JOURNAL   Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
            DOI:10.1152/ajpgi.00334.2017
REFERENCE   PMID:24385684
  AUTHORS   Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  TITLE     The effect of inflammatory cytokines in alcoholic liver disease.
  JOURNAL   Mediators Inflamm 2013:495156 (2013)
            DOI:10.1155/2013/495156
REFERENCE   PMID:20238398
  AUTHORS   Szabo G, Bala S
  TITLE     Alcoholic liver disease and the gut-liver axis.
  JOURNAL   World J Gastroenterol 16:1321-9 (2010)
            DOI:10.3748/wjg.v16.i11.1321
REFERENCE   PMID:28627645
  AUTHORS   Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  TITLE     Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  JOURNAL   Int J Mol Med 40:263-270 (2017)
            DOI:10.3892/ijmm.2017.3015
REFERENCE   PMID:23855294
  AUTHORS   Roh YS, Seki E
  TITLE     Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  JOURNAL   J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
            DOI:10.1111/jgh.12019
REFERENCE   PMID:18709650
  AUTHORS   Rogers CQ, Ajmo JM, You M
  TITLE     Adiponectin and alcoholic fatty liver disease.
  JOURNAL   IUBMB Life 60:790-7 (2008)
            DOI:10.1002/iub.124
REFERENCE   PMID:26278388
  AUTHORS   You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  TITLE     Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  JOURNAL   Curr Mol Pharmacol 10:226-236 (2017)
            DOI:10.2174/1874467208666150817112109
REFERENCE   PMID:26005675
  AUTHORS   You M, Jogasuria A, Taylor C, Wu J
  TITLE     Sirtuin 1 signaling and alcoholic fatty liver disease.
  JOURNAL   Hepatobiliary Surg Nutr 4:88-100 (2015)
            DOI:10.3978/j.issn.2304-3881.2014.12.06
REFERENCE   PMID:33162823
  AUTHORS   Ren R, Wang Z, Wu M, Wang H
  TITLE     Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  JOURNAL   Int J Biol Sci 16:3174-3183 (2020)
            DOI:10.7150/ijbs.49535
REFERENCE   PMID:19032584
  AUTHORS   Purohit V, Gao B, Song BJ
  TITLE     Molecular mechanisms of alcoholic fatty liver.
  JOURNAL   Alcohol Clin Exp Res 33:191-205 (2009)
            DOI:10.1111/j.1530-0277.2008.00827.x
REFERENCE   PMID:34071962
  AUTHORS   Hyun J, Han J, Lee C, Yoon M, Jung Y
  TITLE     Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  JOURNAL   Int J Mol Sci 22:5717 (2021)
            DOI:10.3390/ijms22115717
REFERENCE   PMID:24297186
  AUTHORS   Combs TP, Marliss EB
  TITLE     Adiponectin signaling in the liver.
  JOURNAL   Rev Endocr Metab Disord 15:137-47 (2014)
            DOI:10.1007/s11154-013-9280-6
REFERENCE   PMID:25548474
  AUTHORS   Ceni E, Mello T, Galli A
  TITLE     Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  JOURNAL   World J Gastroenterol 20:17756-72 (2014)
            DOI:10.3748/wjg.v20.i47.17756
REFERENCE   PMID:31159489
  AUTHORS   Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  TITLE     Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  JOURNAL   Int J Mol Sci 20:E2712 (2019)
            DOI:10.3390/ijms20112712
REFERENCE   PMID:31214376
  AUTHORS   Ohashi K, Pimienta M, Seki E
  TITLE     Alcoholic liver disease: A current molecular and clinical perspective.
  JOURNAL   Liver Res 2:161-172 (2018)
            DOI:10.1016/j.livres.2018.11.002
REFERENCE   PMID:30658725
  AUTHORS   You M, Arteel GE
  TITLE     Effect of ethanol on lipid metabolism.
  JOURNAL   J Hepatol 70:237-248 (2019)
            DOI:10.1016/j.jhep.2018.10.037
REFERENCE   PMID:25595739
  AUTHORS   Bi L, Jiang Z, Zhou J
  TITLE     The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  JOURNAL   Alcohol Alcohol 50:146-51 (2015)
            DOI:10.1093/alcalc/agu102
REFERENCE   PMID:31263795
  AUTHORS   Ali H, Assiri MA, Shearn CT, Fritz KS
  TITLE     Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  JOURNAL   Curr Opin Toxicol 13:110-117 (2019)
            DOI:10.1016/j.cotox.2018.10.003
REFERENCE   PMID:24262277
  AUTHORS   Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  TITLE     Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  JOURNAL   Gastroenterology 146:801-11 (2014)
            DOI:10.1053/j.gastro.2013.11.008
REFERENCE   PMID:22110053
  AUTHORS   Stickel F, Hampe J
  TITLE     Genetic determinants of alcoholic liver disease.
  JOURNAL   Gut 61:150-9 (2012)
            DOI:10.1136/gutjnl-2011-301239
REFERENCE   PMID:29336467
  AUTHORS   Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  TITLE     NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  JOURNAL   Int J Mol Med 41:2306-2316 (2018)
            DOI:10.3892/ijmm.2018.3390
REL_PATHWAY hsa00061  Fatty acid biosynthesis
            hsa00071  Fatty acid degradation
            hsa01040  Biosynthesis of unsaturated fatty acids
            hsa03040  Spliceosome
            hsa04010  MAPK signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04152  AMPK signaling pathway
            hsa04210  Apoptosis
            hsa04310  Wnt signaling pathway
            hsa04610  Complement and coagulation cascades
            hsa04620  Toll-like receptor signaling pathway
            hsa04657  IL-17 signaling pathway
            hsa04668  TNF signaling pathway
            hsa04920  Adipocytokine signaling pathway
            hsa05034  Alcoholism
            hsa05225  Hepatocellular carcinoma
KO_PATHWAY  ko04936
///
